Are there any active or pending lawsuits challenging Yervoy patents?
Yes. Yervoy (ipilimumab) patent coverage has been challenged in the U.S. through Orange Book-related patent litigation (including Hatch-Waxman style disputes) and similar proceedings, where generic- or biosimilar-aspirant companies can challenge one or more listed patents for validity and/or infringement. These challenges typically appear as “pending” cases in federal court dockets or as listings in litigation trackers, but the exact patents and current status can vary by case and by court.
Because patent challenges are time-sensitive and can change case-by-case, the most reliable way to confirm “pending” status today is to check:
- The U.S. FDA Orange Book for Yervoy and then the specific listed patents (and their case numbers, when available)
- Federal court dockets tied to those patent numbers
- Public litigation databases and alerts that track Orange Book/Hatch-Waxman disputes
Which patents for Yervoy are usually the targets of challenges?
Challenges commonly target patents covering one or more of the following categories:
- Formulation or manufacturing/process claims (how the drug is made)
- Method-of-use claims (specific clinical regimens or endpoints)
- Composition-of-matter or related IP that supports exclusivity
In practice, the “what exactly is being challenged” depends on which patents are listed for Yervoy at the time the generic/biosimilar applicant files its paragraph-IV-type challenge (or similar mechanism).
How can you check whether a Yervoy patent challenge is still pending?
To determine whether a challenge is still pending (as opposed to settled or fully decided), look for these signals in the docket or reporting:
- A case caption naming the applicant and the brand company (and the patent number(s) at issue)
- Recent docket entries (motions, hearings, appeals, or injunction-related filings)
- Whether the dispute is at the trial, appeal, or enforcement stage
- Whether there are stayed or remanded proceedings
If you share the specific patent number(s) you mean (or the country/jurisdiction), I can tell you what to look for in the corresponding docket entries.
Does “pending legal challenge” mean the patent is invalid?
Not automatically. A pending challenge means the issue is still being litigated or otherwise resolved. Courts can ultimately find:
- the patent is invalid, or not infringed, which can open the door to earlier competition, or
- the patent is valid and infringed, which can block entry until expiry or settlement.
Pending status alone does not indicate the outcome.
What jurisdiction matters (US vs. other countries)?
“Pending challenges” can exist in multiple jurisdictions, but they won’t always mirror each other:
- The U.S. system tied to the Orange Book and federal court filings is a common source of patent disputes.
- Other countries may have separate patent litigation tracks with different timing and standards.
So the answer depends on where you’re asking about (U.S., EU member states, UK, etc.).
If you want, I can narrow it down quickly
If you tell me either:
1) the jurisdiction (e.g., U.S.), and
2) the patent number(s) or the product label version you’re looking at,
I can help you identify which challenges are actually “pending” for those specific patents and how to verify the current status in public records.